SLC11A2 and posterior cortical atrophy: This information taken together has led to the hypothesis that the STEAP family, along with DMT1, may be able to identify the extent of disease and therefore aid the prognosis of PCa patients, resulting in the administration of more suitable treatments on a patient by patient basis.